Aignostics
@aignostics.com
Aignostics turns complex biomedical data into transformative insights for biopharma companies through development of AI-powered precision medicine for pathology throughout the drug development pipeline from target identification, to translational research, and trials & companion diagnostics.
Aignostics's Company Logos
Aignostics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#423D6B
East Bay
66, 61, 107
247, 27, 33
38, 43, 0, 58
#DA966D
Burning Sand
218, 150, 109
23, 60, 64
0, 31, 50, 15
#1C1242
Haiti
28, 18, 66
252, 57, 16
58, 73, 0, 74
About Aignostics
Aignostics is a pioneering company established in 2018, stemming from extensive research at Charité Berlin and the Berlin Institute of Health. The company’s mission is to advance precision medicine by leveraging artificial intelligence in the realm of computational pathology. Spun out in 2020, Aignostics operates from offices in Berlin and New York, focusing on innovative solutions for pharmaceutical research, clinical trials, and companion diagnostics (CDx) development.
The interdisciplinary team consists of over 100 professionals, including computer scientists, MDs, and PhDs, hailing from more than 30 nationalities. Their expertise fuels advancements that bridge the gap between technology and health research, underpinned by substantial collaboration with six research partners and a robust portfolio of around 800 publications. Aignostics is committed to making strides in precision diagnostics, ultimately transforming healthcare through the integration of AI and pathology, thus setting a new standard in medical technology and research applications.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
